ABBV vs MRK: stock comparison and AI forecast
Abbvie Inc. (ABBV) and Merck & Co., Inc. (MRK) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ABBV Abbvie Inc.
- Market Cap
- $509.35B
- P/E Ratio
- 44.1x
- Size
- mega-cap
- AI Forecast
MRK Merck & Co., Inc.
- Price
- $146.94 +30.8% · 6M
- Market Cap
- $362.53B
- P/E Ratio
- 151.5x
- Size
- mega-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ABBV is 1.4 times larger than MRK by market capitalization ($509.35B against $362.53B).
- ABBV trades at 44.1 times trailing earnings, MRK at 151.5 times.
- ABBV turns 15.7% of its revenue into net income, against 3.6% for MRK.
- ABBV yields 2.38% in dividends and MRK 2.31%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ABBV | MRK |
|---|---|---|
| Market Cap | $509.35B | $362.53B |
| P/E Ratio | 44.14x | 151.48x |
| P/B Ratio | – | 8.08x |
| Dividend Yield | 2.38% | 2.31% |
| EPS | $6.53 | $0.97 |
| Book Value/Share | – | $18.20 |
| Revenue/Share | $37.36 | $27.31 |
| FCF/Share | $10.68 | $5.98 |
Profitability & Margins
| Metric | ABBV | MRK |
|---|---|---|
| ROE | – | 5.5% |
| ROA | 7.0% | 1.9% |
| ROIC | 20.3% | – |
| Gross Margin | 73.7% | 71.8% |
| Operating Margin | 32.2% | – |
| Net Margin | 15.7% | 3.6% |
| EBT Margin | 19.4% | 7.1% |
| Tax Rate | 19.2% | 48.5% |
Financial Health
| Metric | ABBV | MRK |
|---|---|---|
| Current Ratio | 0.87x | 1.35x |
| Quick Ratio | 0.75x | 1.14x |
| D/E Ratio | – | 1.96x |
| Financial Leverage | – | 2.96x |
| Interest Coverage | 7.8x | – |
| Working Capital | -$5.62B | $10.14B |
Cash Flow
| Metric | ABBV | MRK |
|---|---|---|
| Operating Cash Flow | $20.09B | $18.70B |
| Free Cash Flow | $18.87B | $14.75B |
| Capital Spending | -$1.22B | -$3.96B |
| OCF Growth YoY | -3.7% | 9.6% |
| FCF Growth YoY | -4.1% | 13.0% |
| FCF/Sales | 28.6% | 21.9% |
| CapEx/Sales | 1.8% | 5.9% |
Operational Efficiency
| Metric | ABBV | MRK |
|---|---|---|
| Asset Turnover | 0.45x | 0.51x |
| Receivables Turnover | 4.9x | 5.3x |
| Inventory Turnover | 3.3x | 3.1x |
| Fixed Assets Turnover | 11.1x | 2.6x |
| Days Sales Outstanding | 75 days | 69 days |
| Days Inventory | 112 days | 118 days |
| Payables Period | 724 days | 96 days |
| Cash Conversion Cycle | -538 days | 91 days |
Income Statement
| Metric | ABBV | MRK |
|---|---|---|
| Total Revenue | $66.01B | $67.38B |
| Operating Income | $21.23B | – |
| Net Income | $10.34B | $2.45B |
| R&D Expense | $9.96B | $30.76B |
| SG&A Expense | $15.19B | $11.39B |
| Cost of Goods Sold | $17.35B | $19.03B |
Dividend & Shareholder Information
| Metric | ABBV | MRK |
|---|---|---|
| Dividends Per Share | $6.87 | $3.39 |
| Payout Ratio | 105.2% | 349.5% |
| Shares Outstanding | 1767M | 2467M |
| Net Income Growth | 333.1% | -87.1% |
| EPS Growth | 380.1% | -87.2% |
ABBV vs MRK: stock comparison and AI forecast
Which is bigger, ABBV or MRK?
ABBV is 1.4 times larger than MRK by market capitalization ($509.35B against $362.53B).
Which is cheaper on earnings, ABBV or MRK?
ABBV trades at 44.1 times trailing earnings, MRK at 151.5 times.
Which one does Intratio's AI model rank higher, ABBV or MRK?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.